TLS risk assessment with CLL therapies
EHA Learning Center, Session Speakers, 209967
TLS prophylaxis and monitoring
EHA Learning Center, Session Speakers, 209966
Clinical management of TLS
EHA Learning Center, Session Speakers, 209965
Anaemia in renal failure
EHA Learning Center, Sule Unal, 208527
Differential diagnosis of a microcytic anaemia
EHA Learning Center, Barbara Bain, 208526
Glucocorticoids Induce Differentiation Of Monocytes Towards Macrophages That Share Functional And Phenotypical Aspects With Erythroblastic Island Macrophages
EHA Learning Center, Esther Heideveld, 209110
MiR-144/451 Represses The LKB1/AMPK/MTOR Pathway To Promote Red Cell Precursor Survival During Recovery From Acute Anemia
EHA Learning Center, Xiao Fang, 209111
Hypomorphic FANCA Mutations Correlate With Mild Mitochondrial And Clinical Phenotype In Fanconi Anemia
EHA Learning Center, Roberta Bottega, 209112
Constitutional SAMD9L Mutations Cause Familial Myelodysplastic Syndrome And Transient Monosomy 7
EHA Learning Center, Victor B. Pastor, 209113
Benefits And Pitfalls Of Pegylated Interferon-Α2a Therapy In Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis: A French Intergroup Of Myeloproliferative Neoplasms (FIM) Study
EHA Learning Center, Jean-Christophe Iannotto, 209114
CD36 Defines Primitive Chronic Myeloid Leukemia Cells Less Responsive To Imatinib But Vulnerable To Antibody-Based Therapeutic Targeting
EHA Learning Center, Nuklas Landberg, 209115
Chemotherapy-Induced Differential Cell Cycle Arrest In B-Cell Lymphomas Affects Their Sensitivity To Wee1 Inhibition
EHA Learning Center, Xiaoguang Wang, 209117
Blood Cytokine Concentrations In Pediatric Patients With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
EHA Learning Center, Fabian Knörr, 209118
Clinicopathological Characteristics Of T-Cell Non-Hodgkin Lymphoma Arising In Patients With Immunodeficiencies: A Single-Center Case Series Of 25 Patients And A Review Of The Literature
EHA Learning Center, Marieke L. Nijland, 209119
In Vitro And In Vivo Evidence For Uncoupling Of B-Cell Receptor Internalization And Signaling In Chronic Lymphocytic Leukemia
EHA Learning Center, Eve M. Coulter, 209120
Outcome And Survival Of Myeloma Patients Diagnosed 2008–2015. Real-World Data On 4904 Patients From The Swedish Myeloma Registry
EHA Learning Center, Cecile Hveding Blimark, 209121
Melphalan 140 Mg/M2 Or 200 Mg/M2 For Autologous Transplantation In Myeloma: Results From The Collaboration To Collect Autologous Transplant Outcomes In Lymphoma And Myeloma (CALM) Study. A Report By The EBMT Chronic Malignancies Working Party
EHA Learning Center, Holge W. Auner, 209122
Bortezomib-Based Immunosuppression After Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation: Randomized Phase II Results
EHA Learning Center, John Koreth, 209123
In Vivo IL-12/IL-23p40 Neutralization Blocks Th1/Th17 Response After Allogeneic Hematopoietic Cell Transplantation
EHA Learning Center, Joseph Pidala, 209124
Variable Impairment Of Platelet Functions In Patients With Severe, Genetically Linked Immune Deficiencies
EHA Learning Center, Magdolna Nagy, 209125
Desmopressin In Moderate Hemophilia A Patients: A Treatment Worth Considering
EHA Learning Center, Janneke I. Loomans, 209126
Group 1 forum discussion
EHA Learning Center, Session Speakers, 208324
Group 2 forum discussion
EHA Learning Center, Session Speakers, 208325
Group 1 forum discussion
EHA Learning Center, Session Speakers, 208326
Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in Europe
EHA Learning Center, Jochen Buechner, 209978
Immune Checkpoint Inhibition in Hodgkin Lymphoma
EHA Learning Center, Ryan H. Moy, 209979
Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism
EHA Learning Center, Sake van der Wall, 209980
Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group
EHA Learning Center, Alice Marceau-Renaut, 209981
A challenging course through a difficult landscape
EHA Learning Center, Delivered by Janssen, 205759
Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia
EHA Learning Center, Etienne Lengline, 206303
Rational management approach to pure red cell aplasia
EHA Learning Center, Suresh Kumar Balasubramanian, 206304
The clinical and laboratory evaluation of familial hemophagocytic lymphohistiocytosis and the importance of hepatic and spinal cord involvement: a single center experience
EHA Learning Center, Burcin Beken, 206305
Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation
EHA Learning Center, Christoph Schmid, 206306
Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
EHA Learning Center, Xavier Poiré, 206308
Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression
EHA Learning Center, Sean I. Tracy, 206312
Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantation
EHA Learning Center, Jennifer Mosebach, 206316
Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage
EHA Learning Center, Travis Nemkov, 206319
Protein Arginine Methyltransferase 6 Controls Erythroid Gene Expression And Differentiation Of Human CD34+ Progenitor Cells
EHA Learning Center, Stefanie Herkt, 205316
Cancer In The National Cancer Institute Inherited Bone Marrow Failure Syndrome Cohort After Fifteen Years Of Follow-Up
EHA Learning Center, Blanche P. Alter, 205317
Expansion Of EPOR-Negative Macrophages Besides Erythroblasts By Elevated EPOR Signaling In Erythrocytosis Mouse Models
EHA Learning Center, Jieyu Wang, 205318
Treatment Of Essential Thrombocythemia In Europe: A Prospective Long-Term Observational Study Of 3649 High-Risk Patients In The Evaluation Of Anagrelide Efficacy And Long-Term Safety Study
EHA Learning Center, Gunnar Birgegard, 205319
Erythropoietin Inhibits Osteoblast Function In Myelodysplastic Syndromes Via The Canonical Wnt Pathway
EHA Learning Center, Ekaterina Balaian, 205320
Labile Plasma Iron Levels Predict Survival In Patients With Lower-Risk Myelodysplastic Syndromes
EHA Learning Center, Louise de Swart, 205321
Depletion Of SIRT6 Enzymatic Activity Increases Acute Myeloid Leukemia Cells’ Vulnerability To DNA-Damaging Agents
EHA Learning Center, Antonia Cagnetta, 205322
Variable Outcome And Methylation Status According To CEBPA Mutant Type In Double-Mutated Acute Myeloid Leukemia Patients And The Possible Implications For Treatment
EHA Learning Center, Dima El-Sharkawi, 205323
Randomized Study Of Continuous High-Dose Lenalidomide, Sequential Azacitidine And Lenalidomide, Or Azacitidine In Persons 65 Years And Over With Newly-Diagnosed Acute Myeloid Leukemia
EHA Learning Center, Bruno Medeiros, 205324
Predictive Value Of Minimal Residual Disease In Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia Treated With Imatinib In The European Intergroup Study Of Post-Induction Treatment Of Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia, Based On Immunoglobulin/T-Cell Receptor And BCR/ABL1 Methodologies
EHA Learning Center, Giovanni Cazzaniga, 205325
Inhibition Of Focal Adhesion Kinase Overcomes Resistance Of Mantle Cell Lymphoma To Ibrutinib In The Bone Marrow Microenvironment
EHA Learning Center, Martina Rudelius, 205326
Histone Deacetylase Inhibitors Downregulate CCR4 Expression And Decrease Mogamulizumab Efficacy In CCR4-Positive Mature T-Cell Lymphomas
EHA Learning Center, Akihiro Kitadate, 205327
Microenvironmental Stromal Cells Abrogate NF-ΚB Inhibitor-Induced Apoptosis In Chronic Lymphocytic Leukemia
EHA Learning Center, Carl Philipp Simona-Gabriel, 205328
Introducing High-Throughput Sequencing Into Mainstream Genetic Diagnosis Practice In Inherited Platelet Disorders
EHA Learning Center, Jose Maria Bastida Bermejo, 205329
Comparative Profiling Of HLA-DR And HLA-DQ Associated Factor VIII Peptides Presented By Monocyte-Derived Dendritic Cells
EHA Learning Center, Ivan Peyron, 205331
Analyses Of The FranceCoag Cohort Support Differences In Immunogenicity Among One Plasma-Derived And Two Recombinant Factor VIII Brands In Boys With Severe Hemophilia A
EHA Learning Center, Thierry Calvez, 205332
How to treat adolescents with ALL
EHA Learning Center, Wendy Stock, 206322
Ham Wassermann Lecture
EHA Learning Center, Giampaolo Merlini, 206325
NETs as friends or foes
EHA Learning Center, Christian Yost, 206326
Next Generation sequencing as a diagnostic tool for precision medicine
EHA Learning Center, Torsten Haferlach, 206327
Interview with the president of the American Society of Hematology
EHA Learning Center, Kenneth Anderson, 206328
TTP in remission. To treat or not.
EHA Learning Center, Paul Coppo, 206329
Targeting activated protein C to treat hemophilia
EHA Learning Center, James Huntington, 206330
Platelet regulation of tumor growth and metastases
EHA Learning Center, Anil Sood, 206331
Is Good Clinical Practice Becoming Poor Clinical Care?
EHA Learning Center, Steven LE GOUILL, 207948
Myelofibrosis-Related Anemia: Current and Emerging Therapeutic Strategies
EHA Learning Center, Leonard Naymagon, 207949
Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German...
EHA Learning Center, Andreas Engert, 207950
Early Markers of Sickle Nephropathy in Children With Sickle Cell Anemia Are Associated With Red Cell Cation Transport Activity
EHA Learning Center, John Brewin, 207951
E-course on MDS
EHA Learning Center, Session Speakers, 193787
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases
EHA Learning Center, Staci D. Arnold, 203121
The ADAMTS131239–1253 peptide is a dominant HLA-DR1-restricted CD4+ T-cell epitope
EHA Learning Center, Laurent Gilardin, 203122
Treatment outcome in a population-based, ‘real-world’ cohort of patients with chronic myeloid leukemia
EHA Learning Center, Inge , 203123
Senescence is a Spi1-induced anti-proliferative mechanism in primary hematopoietic cells
EHA Learning Center, Laure Delestré, 203124
Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm
EHA Learning Center, Laure Philippe, 203125
Antigen receptor sequencing of paired bone marrow samples shows homogeneous distribution of acute lymphoblastic leukemia subclones
EHA Learning Center, Prisca M.J. Theunissen, 203126
Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitor
EHA Learning Center, Tiziana Vaisitti, 203127
SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia
EHA Learning Center, Cody Paiva, 203128
Toll-like receptor 9 stimulation can induce IκBζ expression and IgM secretion in chronic lymphocytic leukemia cells
EHA Learning Center, Eleonora Fonte, 203129
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study
EHA Learning Center, Pieternella Lugtenburg, 203130
CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial
EHA Learning Center, Yasuhiro Oki, 203131
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma
EHA Learning Center, Alessandro Broccoli, 203132
CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results
EHA Learning Center, Amina Kariminia, 203133
Human leukocyte antigen-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients
EHA Learning Center, Chrysanthi Tsamadou, 203134
HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis
EHA Learning Center, Rui Huang, 203135
Emerging treatment goals in chronic myeloid lymphoma
EHA Learning Center, Delivered by Novartis, 202870
HME FORUM Optimizing Outcomes For Patients With CLL
EHA Learning Center, Delivered by Janssen, 202871
HME FORUM The Clinical Implications of Our Improved Understanding Of CLL Biology
EHA Learning Center, Delivered by Janssen, 202872
Curriculum: EHA Bite-size Master Class - Thalassemia, Thrombosis and Transplantation
EHA Learning Center, Session Speakers, 170359
EHA Learning Center, Session Speakers, 202319
EHA Learning Center, Session Speakers, 202322
Molecular pathology of Hodgkin´s lymphoma and prognostic implications
EHA Learning Center, Randy Gascoyne, 145397
The role of clinical prognostic factors in the PET era
EHA Learning Center, Laurie H. Sehn, 145398
Current approaches in the treatment of HL
EHA Learning Center, Massimo Federico, 145399
Radiotherapy in Hodgkin's Lymphoma: which dose and for whom
EHA Learning Center, Andreas Engert, 145400
New drugs in the treatment of relapsed / refractory Hodgkin's Lymphoma
EHA Learning Center, Anas Younes, 145401
New treatment approaches in Hodgkin lymphoma in 2016
EHA Learning Center, Igor Aurer, 145402
Role of auto and allografts in Hodgkin lymphoma
EHA Learning Center, Anna Sureda, 145403
Late Effects of Hodgkin Lymphoma Treatment: Implications for Management of Contemporary Patients
EHA Learning Center, Simonetta Viviani, 145404
The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints
EHA Learning Center, Anas Younes, 145406
Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study
EHA Learning Center, Julien Lazarovici, 145407
eCourse on Hodgkin lymphoma
EHA Learning Center, Session Speakers, 145408
Pregnancy in Non-Transfusion-dependent Thalassemia
EHA Learning Center, Ali Taher, 142871
A Taher - Non-transfusion-dependent Thalassemia (NTDT)
EHA Learning Center, Ali Taher, 183891